BioLineRx (BLRX) Tops Q1 EPS by 11c

BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.11 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Colony Bankcorp to acquire First Reliance in $163M stock-and-cash deal
• Micron posts record profit as AI memory demand fuels explosive growth